Production (Stage)
Third Harmonic Bio, Inc.
THRD
$5.18
-$0.02-0.39%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 23.38M | 22.37M | 20.96M | 20.11M | 19.80M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 64.30M | 58.87M | 52.84M | 46.61M | 43.26M |
Operating Income | -64.30M | -58.87M | -52.84M | -46.61M | -43.26M |
Income Before Tax | -53.45M | -45.47M | -39.20M | -32.74M | -29.60M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -53.45 | -45.47 | -39.20 | -32.74 | -29.60 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -53.45M | -45.47M | -39.20M | -32.74M | -29.60M |
EBIT | -64.30M | -58.87M | -52.84M | -46.61M | -43.26M |
EBITDA | -64.25M | -58.82M | -52.79M | -46.56M | -43.21M |
EPS Basic | -1.24 | -1.09 | -0.96 | -0.82 | -0.74 |
Normalized Basic EPS | -0.75 | -0.68 | -0.60 | -0.51 | -0.46 |
EPS Diluted | -1.24 | -1.09 | -0.96 | -0.82 | -0.74 |
Normalized Diluted EPS | -0.75 | -0.68 | -0.60 | -0.51 | -0.46 |
Average Basic Shares Outstanding | 171.62M | 166.92M | 161.97M | 160.34M | 159.35M |
Average Diluted Shares Outstanding | 171.62M | 166.92M | 161.97M | 160.34M | 159.35M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |